Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Urol ; 205(6): 1704-1709, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-33502240

RESUMEN

PURPOSE: It is well documented that the prevalence of nephrolithiasis is increasing in adults in the United States over time. Approximately 11% of men and 7% of women have reported a lifetime history of nephrolithiasis in cross-sectional studies. However, the burden of acute management may be better assessed from annual cumulative incidence. This accounting of new stone occurrences, however, is not well described on a national scale. MATERIALS AND METHODS: The Medical Expenditure Panel Survey is a set of large-scale health care utilization surveys of families, individuals, their health care providers and employers, with surveys administered every 6 months for the duration of each individual's 2-year panel. We queried the survey data of adult participants between 2005 and 2015, with analysis conducted with provided weights and strata to allow our findings to be representative of the civilian noninstitutionalized U.S. adult population. Those with diagnosed renal or ureteral calculi as noted by ICD-9 codes were included as our incident stone formers. RESULTS: In 2005, the mean age of stone formers was 45 years. Of stone formers 52.2% were male, 91% were White and 47.6% were in the Southern U.S. The incidence of stone occurrences was 0.6% (177/33,961 individuals, weighted to represent population of 1,923,322/296,185,002 individuals). By 2015, the mean age was 51.7 years, with 52% male, 83% White and 38.2% residing in the Southern U.S. Between 2005 and 2015, the overall incidence increased from 0.6% to 0.9% (p <0.001). CONCLUSIONS: Based on this large-scale, nationally representative analysis of adults in the United States, the estimated annual cumulative incidence of stone occurrence is approaching 1%. Moreover, this incidence appears to be increasing over time, rising from 0.6% in 2005 to 0.9% in 2015. These data may help to better anticipate the need for urological care for stone disease and direct resource distribution.


Asunto(s)
Cálculos Renales/epidemiología , Adulto , Estudios de Cohortes , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Prevalencia , Factores de Tiempo , Estados Unidos/epidemiología
2.
Urology ; 141: e45-e46, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32305553

RESUMEN

The development and management of necrotizing cellulitis following penile constriction ring use is described. Devastating injuries such as this can be highly distressing for patients and focused counseling is often needed to address concerns regarding cosmetic outcomes. The timeframe and appearance of recovery has not been previously captured. We present a photographic timeline covering the development, management, and postoperative recovery from penile constriction ring injury over the course of 1 month.


Asunto(s)
Celulitis (Flemón)/microbiología , Enfermedades del Pene/microbiología , Pene/lesiones , Infecciones Estreptocócicas/etiología , Streptococcus pyogenes , Celulitis (Flemón)/diagnóstico , Celulitis (Flemón)/cirugía , Humanos , Masculino , Persona de Mediana Edad , Enfermedades del Pene/diagnóstico , Enfermedades del Pene/cirugía , Factores de Tiempo
3.
Urology ; 133: 103-108, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31377258

RESUMEN

OBJECTIVE: To characterize shock wave lithotripsy (SWL) utilization and assess for regional variation in the use of this procedure across the United States. MATERIALS AND METHODS: We examined SWL and URS utilization among Medicare Beneficiaries with a diagnosis of nephrolithiasis for the years 2006, 2009, and 2014. Adjusted utilization rates were calculated per 1000 beneficiaries accounting for age, sex, and race. Utilization rates were examined nationally and by hospital referral region (HRR). RESULTS: A total of 511,495, 604,493, and 806,652 Medicare beneficiaries had a diagnosis of nephrolithiasis in 2006, 2009, and 2014, respectively. The adjusted rate of SWL per 1000 beneficiaries with nephrolithiasis decreased from 59.4/1000 in 2006 to 52.2/1000 and 45.5/1000 in 2009 and 2014 (13.9% decrease, P < .001). Variation was observed in SWL utilization; up to a 12-fold difference between HRRs (9.2/1000 in Winchester, VA to 105.8/1000 in Lincoln, NE). The adjusted rate of URS per 1000 beneficiaries increased by 10.2% (P < .001) between 2006 and 2014. However, the percent decrease in SWL utilization did not correlate with the percent increase in URS utilization when examined by HRR (P = .66). CONCLUSION: Variation exists in the utilization of SWL among Medicare beneficiaries (12-fold difference). This variation is likely secondary to a series of supply, urologist, and patient-specific factors. SWL utilization decreased between 2006 and 2014, while URS increased. Stone procedure type is likely highly dependent on where patients receive their urologic care.


Asunto(s)
Cálculos Renales/terapia , Litotricia/estadística & datos numéricos , Pautas de la Práctica en Medicina/estadística & datos numéricos , Utilización de Procedimientos y Técnicas/estadística & datos numéricos , Anciano , Femenino , Humanos , Masculino , Medicare , Estados Unidos
4.
J Urol ; 200(6): 1273-1277, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30059688

RESUMEN

PURPOSE: Although urolithiasis affects each gender, conventional teaching proposes that men are 3 times more likely to have stones. However, clinical practice refutes such a disparity, particularly among working age adults. Small studies have suggested an erosion of this gender gap. Therefore, we examined the relationship between gender and stone prevalence among American adults younger than 50 years. MATERIALS AND METHODS: We analyzed the NHANES (National Health and Nutrition Examination Survey) 2007 to 2012 cohort. Weighted proportions and multivariate logistic regression of the cohort and pertinent subgroups were assessed to determine the prevalence and the odds of nephrolithiasis. RESULTS: The cohort of 17,658 subjects, which was weighted to represent the American population of 218,828,951 adults, was 48.1% male. In our cohort of 8,888 adults weighted to represent 123,976,786 subjects younger than 50 years, which was 49.3% male and 50.7% female, there was no difference in stone prevalence (6.3% in males and 6.4% in females, p = 0.85). On unadjusted logistic regression of those younger than 50 years men were no more likely to report a stone history (OR 0.98, p = 0.85). Multivariate logistic regression adjusting for diabetes, obesity, ethnicity, age, and water, sodium and protein intake confirmed no difference in stone prevalence between the genders (OR 1.1, p = 0.51). CONCLUSIONS: Among adults of working and child rearing ages in the United States the much touted gender disparity in nephrolithiasis is not present. Prior assessments of gender based stone prevalence may have failed to specifically assess this economically critical demographic or there may in fact be an ongoing epidemiological change. Recognition that women are as likely as men to form stones in this cohort suggests the need to better elucidate the pathophysiology of stones in women.


Asunto(s)
Disparidades en el Estado de Salud , Cálculos Renales/epidemiología , Encuestas Nutricionales/estadística & datos numéricos , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Distribución por Sexo , Estados Unidos/epidemiología , Adulto Joven
5.
Urol Case Rep ; 11: 50-52, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28149749

RESUMEN

Pneumoscrotum and subcutaneous emphysema make for impressive findings on examination and imaging. With ranging etiologies, thorough investigation into the source is essential to rule out potentially life threatening situations. We present a 31-year-old man with pneumoscrotum and extensive subcutaneous emphysema of his penis, abdomen, and perineum. History and physical exam didn't reveal a clear cause and he subsequently underwent surgical exploration showing no soft tissue infection. On post-operative day 1, he remained clinically stable and was discharged. Despite the usual benign nature of pneumoscrotum, full assessment is necessary to identify possible underlying conditions of significant morbidity and mortality.

6.
Prehosp Disaster Med ; 28(5): 477-81, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23962769

RESUMEN

INTRODUCTION: High-dose intravenous nitroglycerin is a common in-hospital treatment for respiratory distress due to congestive heart failure (CHF) with hypertension. Intravenous (IV) nitroglycerin administration is impractical in the prehospital setting. In 2011, a new regional Emergency Medical Services (EMS) protocol was introduced allowing advanced providers to treat CHF with high-dose oral nitroglycerin. The protocol calls for patients to be treated with two sublingual tabs (0.8 mg) when systolic blood pressure (SBP) was >160 mm Hg, or three sublingual tabs (1.2 mg) when SBP was >200 mm Hg, every five minutes as needed. Hypothesis/Problem To assess the protocol's safety, the incidence of hypotension following prehospital administration of multiple simultaneous nitroglycerin (MSN) tabs by EMS providers was studied. METHODS: This study was a retrospective cohort study of patients from a single commercial EMS agency over a 6-month period. Records from patients with at least one administration of MSN were reviewed. For each administration, the first documented vital signs pre- and post-administration were compared. Administrations were excluded if pre- or post-administration vital signs were missing. RESULTS: One hundred case-patients had at least one MSN administration by an advanced provider during the study period. Twenty-five case-patients were excluded due to incomplete vital signs. Seventy-five case-patients with 95 individual MSN administrations were included for analysis. There were 65 administrations of two tabs, 29 administrations of three tabs, and one administration of four tabs. The mean change in SBP following MSN was -14.7 mm Hg (SD = 30.7; range, +59 to -132). Three administrations had documented systolic hypotension in the post-administration vital signs (97/71, 78/50 and 66/47). All three patients were over 65 years old, were administered two tabs, had documented improved respiratory status, and had repeat SBP of at least 100. The incidence of hypotension following MSN administration was 3.2%. Discussion High-dose oral nitroglycerin administration is a practical alternative to IV nitroglycerin in the prehospital setting when administered by advanced providers. The prehospital protocol for high dose oral nitroglycerin was demonstrated to be safe in the cohort of patients studied. Limitations of the study include the relatively small sample size and the inability to identify hypotension that may have occurred following the cessation of data collection in the field. CONCLUSION: Hypotension was rare and self-limited in prehospital patients receiving MSN.


Asunto(s)
Relación Dosis-Respuesta a Droga , Servicios Médicos de Urgencia , Hipotensión/inducido químicamente , Nitroglicerina/efectos adversos , Vasodilatadores/efectos adversos , Administración Sublingual , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Insuficiencia Cardíaca/tratamiento farmacológico , Humanos , Masculino , Auditoría Médica , Persona de Mediana Edad , Nitroglicerina/administración & dosificación , Estudios Retrospectivos , Vasodilatadores/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...